Skip to main content
Premium Trial:

Request an Annual Quote

Jeff Elliott

Exact Sciences has appointed Jeff Elliott as vice president of business development and strategy. Effective June 20, Elliott will oversee the identification and pursuit of strategic business opportunities while also helping drive sales of Exact’s Cologuard colon cancer test. Most recently, Elliott worked as a senior research analyst covering the diagnostic and lab industries for Exact. He previously worked at Robert W. Baird as a senior research analyst covering diagnostics and life science tools companies. Elliott has also worked in a supply chain role for Walgreens and as a consultant at Cap Gemini Ernst & Young.

The Scan

Push Toward Approval

The Wall Street Journal reports the US Food and Drug Administration is under pressure to grant full approval to SARS-CoV-2 vaccines.

Deer Exposure

About 40 percent of deer in a handful of US states carry antibodies to SARS-CoV-2, according to Nature News.

Millions But Not Enough

NPR reports the US is set to send 110 million SARS-CoV-2 vaccine doses abroad, but that billions are needed.

PNAS Papers on CRISPR-Edited Cancer Models, Multiple Sclerosis Neuroinflammation, Parasitic Wasps

In PNAS this week: gene-editing approach for developing cancer models, role of extracellular proteins in multiple sclerosis, and more.